Literature DB >> 23702776

SWI/SNF chromatin remodeling enzymes are associated with cardiac hypertrophy in a genetic rat model of hypertension.

Aanchal Mehrotra1, Bina Joe, Ivana L de la Serna.   

Abstract

Pathological cardiac hypertrophy is characterized by a sustained increase in cardiomyocyte size and re-activation of the fetal cardiac gene program. Previous studies implicated SWI/SNF chromatin remodeling enzymes as regulators of the fetal cardiac gene program in surgical models of cardiac hypertrophy. Although hypertension is a common risk factor for developing cardiac hypertrophy, there has not yet been any investigation into the role of SWI/SNF enzymes in cardiac hypertrophy using genetic models of hypertension. In this study, we tested the hypothesis that components of the SWI/SNF complex are activated and recruited to promoters that regulate the fetal cardiac gene program in hearts that become hypertrophic as a result of salt induced hypertension. Utilizing the Dahl salt-sensitive (S) rat model, we found that the protein levels of several SWI/SNF subunits required for heart development, Brg1, Baf180, and Baf60c, are elevated in hypertrophic hearts from S rats fed a high salt diet compared with normotensive hearts from Dahl salt-resistant (R) rats fed the same diet. Furthermore, we detected significantly higher levels of SWI/SNF subunit enrichment as well as evidence of more accessible chromatin structure on two fetal cardiac gene promoters in hearts from S rats compared with R rats. Our data implicate SWI/SNF chromatin remodeling enzymes as regulators of gene expression in cardiac hypertrophy resulting from salt induced hypertension. Thus we provide novel insights into the epigenetic mechanisms by which salt induced hypertension leads to cardiac hypertrophy.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23702776      PMCID: PMC4040522          DOI: 10.1002/jcp.24404

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  30 in total

1.  Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene.

Authors:  S Rao; E Procko; M F Shannon
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

2.  Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

Review 3.  Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers.

Authors:  Ivana L de la Serna; Yasuyuki Ohkawa; Anthony N Imbalzano
Journal:  Nat Rev Genet       Date:  2006-06       Impact factor: 53.242

Review 4.  Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.

Authors:  Bianca C Bernardo; Kate L Weeks; Lynette Pretorius; Julie R McMullen
Journal:  Pharmacol Ther       Date:  2010-05-12       Impact factor: 12.310

Review 5.  Challenges and opportunities for cardiovascular disease prevention.

Authors:  Manuel Franco; Richard S Cooper; Usama Bilal; Valentín Fuster
Journal:  Am J Med       Date:  2011-02       Impact factor: 4.965

6.  Cardiac genes show contextual SWI/SNF interactions with distinguishable gene activities.

Authors:  Lisa Chang; Helen Kiriazis; Xiao-Ming Gao; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

7.  Polybromo protein BAF180 functions in mammalian cardiac chamber maturation.

Authors:  Zhong Wang; Weiguo Zhai; James A Richardson; Eric N Olson; Juanito J Meneses; Meri T Firpo; Chulho Kang; William C Skarnes; Robert Tjian
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

Review 8.  Molecular basis of physiological heart growth: fundamental concepts and new players.

Authors:  Marjorie Maillet; Jop H van Berlo; Jeffery D Molkentin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01       Impact factor: 94.444

Review 9.  Molecular regulation of cardiac hypertrophy.

Authors:  Sean P Barry; Sean M Davidson; Paul A Townsend
Journal:  Int J Biochem Cell Biol       Date:  2008-02-26       Impact factor: 5.085

10.  BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.

Authors:  Srinivas V Saladi; Philip G Wong; Archit R Trivedi; Himangi G Marathe; Bridget Keenen; Shweta Aras; Zi-Qi Liew; Vijayasaradhi Setaluri; Ivana L de la Serna
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-02       Impact factor: 4.693

View more
  12 in total

Review 1.  Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.

Authors:  Carolina M Greco; Gianluigi Condorelli
Journal:  Nat Rev Cardiol       Date:  2015-05-12       Impact factor: 32.419

Review 2.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

3.  MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.

Authors:  Gaurav Mehta; Sivarajan Kumarasamy; Jian Wu; Aaron Walsh; Lijun Liu; Kandace Williams; Bina Joe; Ivana L de la Serna
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

Review 4.  Epigenetic modification: a regulatory mechanism in essential hypertension.

Authors:  Mohammed Arif; Sakthivel Sadayappan; Richard C Becker; Lisa J Martin; Elaine M Urbina
Journal:  Hypertens Res       Date:  2019-03-13       Impact factor: 3.872

5.  Mutation within the hinge region of the transcription factor Nr2f2 attenuates salt-sensitive hypertension.

Authors:  Sivarajan Kumarasamy; Harshal Waghulde; Kathirvel Gopalakrishnan; Blair Mell; Eric Morgan; Bina Joe
Journal:  Nat Commun       Date:  2015-02-17       Impact factor: 14.919

Review 6.  Reviewing the Limitations of Adult Mammalian Cardiac Regeneration: Noncoding RNAs as Regulators of Cardiomyogenesis.

Authors:  Robin Verjans; Marc van Bilsen; Blanche Schroen
Journal:  Biomolecules       Date:  2020-02-10

Review 7.  Histone methylation and vascular biology.

Authors:  Xiang Wei; Xin Yi; Xue-Hai Zhu; Ding-Sheng Jiang
Journal:  Clin Epigenetics       Date:  2020-02-18       Impact factor: 6.551

Review 8.  The role and molecular mechanism of epigenetics in cardiac hypertrophy.

Authors:  Hao Lei; Jiahui Hu; Kaijun Sun; Danyan Xu
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

9.  Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.

Authors:  Huanhuan Cui; Jenny Schlesinger; Sophia Schoenhals; Martje Tönjes; Ilona Dunkel; David Meierhofer; Elena Cano; Kerstin Schulz; Michael F Berger; Timm Haack; Salim Abdelilah-Seyfried; Martha L Bulyk; Sascha Sauer; Silke R Sperling
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

10.  Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.

Authors:  Vassilios Myrianthopoulos; Nicolas Gaboriaud-Kolar; Cynthia Tallant; Michelle-Lynn Hall; Stylianos Grigoriou; Peter Moore Brownlee; Oleg Fedorov; Catherine Rogers; David Heidenreich; Marek Wanior; Nikolaos Drosos; Nikitia Mexia; Pavel Savitsky; Tina Bagratuni; Efstathios Kastritis; Evangelos Terpos; Panagis Filippakopoulos; Susanne Müller; Alexios-Leandros Skaltsounis; Jessica Ann Downs; Stefan Knapp; Emmanuel Mikros
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.